Target Price Playground
IBLC
$31.92
Forward Projection
If price hits $28 by Jan 15
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Moderately bearish. Debit, capped max profit + loss.
๐ฏ Target
1-Click Institutional Target Anchors:
60d from today
โ๏ธ Legs
LONG PUT ยท $32 ยท Jan '27
Qty 1 ยท Premium $1.47 ยท ฮ -0.46
SHORT PUT ยท $29 ยท Jan '27
Qty 1 ยท Premium $0.41 ยท ฮ -0.18
P&L at Expiry
Stock (100 sh)
Bear Put Spread
Now
Target
๐ก Stock vs Options at Target
If IBLC hits $28 by Jan 15: the bear put spread returns +$194 (182.4%) on $106 risked, vs $-383 (-12.0%) for 100 shares on $3,192. Options give 15.2ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (60 days out). P&L shown is the value at expiry if IBLC is at $28.
๐ Projected Return
P&L if IBLC hits $28 by Jan 15
+$194
+182.4% on $106 risked
Max Profit
+$194
If the stock โค $29 at expiry
Max Loss
โ$106
Net debit
Break-even
$30.94
-3.08% from spot
Prob. of Profit at Expiry (PoP)
39.9%
Below breakeven ($30.94)
ยท Touch Target: 32%
30-Day Theta Burn (If Flat)
โ$9
8.5% of entry cost ยท Daily ฮ: $-0.31/day
Net ฮ / ฮ / V
-27.84 / -0.31 / 1.73
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| IBLC Price | Today | Dec 6 | Dec 26 | Jan 15 (exp) |
|---|---|---|---|---|
| $26 (-20%) | +$168 | +$179 | +$190 | +$194 |
| $27 (-15%) | +$139 | +$154 | +$175 | +$194 |
| $28 (-12%) โ target | +$115 | +$128 | +$151 | +$194 |
| $29 (-10%) | +$97 | +$108 | +$128 | +$194 |
| $30 (-5%) | +$48 | +$49 | +$52 | +$62 |
| $31 (-2%) | +$18 | +$14 | +$4 | -$34 |
| $32 (0%) โ spot | +$0 | -$8 | -$24 | -$98 |
| $33 (+2%) | -$17 | -$28 | -$48 | -$106 |
| $34 (+5%) | -$40 | -$53 | -$74 | -$106 |
| $35 (+10%) | -$68 | -$80 | -$97 | -$106 |
| $37 (+15%) | -$86 | -$95 | -$104 | -$106 |
| $38 (+20%) | -$96 | -$102 | -$106 | -$106 |
Uses IBLC's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.